Titan Pharmaceuticals
TTNP
TTNP was delisted on the 1st of October, 2025.
19 hedge funds and large institutions have $660K invested in Titan Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 5 closing their positions.
78% more capital invested
Capital invested by funds: $371K → $660K (+$289K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
10% less funds holding
Funds holding: 21 → 19 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$268K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$93.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$82.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$18.9K |
| 5 |
ECM
ETrade Capital Management
Arlington,
Virginia
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$62K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$35K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$5K |
| 4 |
BWA
Beam Wealth Advisors
Covington,
Louisiana
|
-$2K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$469 |
TTNP Hedge Fund Activity: Q1 2020 in Review
19 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q1 2020, worth a combined $660K — up 78% from $371K a quarter earlier.
Fund positioning in TTNP was balanced in Q1 2020: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $268K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $62K sold.
- 19 institutional investors held Titan Pharmaceuticals (TTNP) as of Q1 2020, down from 21 in Q4 2019.
- Funds reported $660K of Titan Pharmaceuticals stock for Q1 2020, up 78% quarter-over-quarter.
- 5 funds opened new Titan Pharmaceuticals positions in Q1 2020 and 5 closed out, a net change of 0 holders.
- The largest Titan Pharmaceuticals buyer in Q1 2020 was Vanguard Group, an estimated $268K added.
- The largest Titan Pharmaceuticals seller in Q1 2020 was Renaissance Technologies, an estimated $62K sold.
Based on aggregated 13F filings for Q1 2020.